Anthony H Nguyen
Examiner (ID: 17425)
Most Active Art Unit | 2854 |
Art Unit(s) | 3307, 2854, 2853 |
Total Applications | 2014 |
Issued Applications | 1600 |
Pending Applications | 48 |
Abandoned Applications | 337 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5595821
[patent_doc_number] => 20060159737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Pharmaceutical compositions for local administration'
[patent_app_type] => utility
[patent_app_number] => 11/267423
[patent_app_country] => US
[patent_app_date] => 2005-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9648
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20060159737.pdf
[firstpage_image] =>[orig_patent_app_number] => 11267423
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/267423 | Pharmaceutical compositions for local administration | Nov 3, 2005 | Abandoned |
Array
(
[id] => 9977077
[patent_doc_number] => 09023384
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-05
[patent_title] => 'Liposome and method for injecting substance to cell using this liposome'
[patent_app_type] => utility
[patent_app_number] => 11/666736
[patent_app_country] => US
[patent_app_date] => 2005-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7740
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11666736
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/666736 | Liposome and method for injecting substance to cell using this liposome | Nov 1, 2005 | Issued |
Array
(
[id] => 4852568
[patent_doc_number] => 20080318311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-25
[patent_title] => 'Encapsulated Bacteriophage Formulation'
[patent_app_type] => utility
[patent_app_number] => 11/666706
[patent_app_country] => US
[patent_app_date] => 2005-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2972
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20080318311.pdf
[firstpage_image] =>[orig_patent_app_number] => 11666706
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/666706 | Encapsulated Bacteriophage Formulation | Nov 1, 2005 | Abandoned |
Array
(
[id] => 5858923
[patent_doc_number] => 20060228776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'PINK-1 promoter'
[patent_app_type] => utility
[patent_app_number] => 11/256372
[patent_app_country] => US
[patent_app_date] => 2005-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 16204
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20060228776.pdf
[firstpage_image] =>[orig_patent_app_number] => 11256372
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/256372 | PINK-1 promoter | Oct 20, 2005 | Abandoned |
Array
(
[id] => 5828978
[patent_doc_number] => 20060063732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Compositions and methods for gene therapy'
[patent_app_type] => utility
[patent_app_number] => 11/253435
[patent_app_country] => US
[patent_app_date] => 2005-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26039
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20060063732.pdf
[firstpage_image] =>[orig_patent_app_number] => 11253435
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/253435 | Compositions and methods for gene therapy | Oct 17, 2005 | Abandoned |
Array
(
[id] => 5721268
[patent_doc_number] => 20060074043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Antisense modulation of matrix metalloproteinase 1 expression'
[patent_app_type] => utility
[patent_app_number] => 11/250884
[patent_app_country] => US
[patent_app_date] => 2005-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25197
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20060074043.pdf
[firstpage_image] =>[orig_patent_app_number] => 11250884
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/250884 | Antisense modulation of matrix metalloproteinase 1 expression | Oct 12, 2005 | Abandoned |
Array
(
[id] => 7499611
[patent_doc_number] => 20110262524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'LIPOSOMES WITH IMPROVED DRUG RETENTION FOR TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 11/576595
[patent_app_country] => US
[patent_app_date] => 2005-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 5373
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20110262524.pdf
[firstpage_image] =>[orig_patent_app_number] => 11576595
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/576595 | Liposomes with improved drug retention for treatment of cancer | Oct 5, 2005 | Issued |
Array
(
[id] => 4718720
[patent_doc_number] => 20080241242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'Porous Polyelectrolyte Materials'
[patent_app_type] => utility
[patent_app_number] => 11/576681
[patent_app_country] => US
[patent_app_date] => 2005-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13936
[patent_no_of_claims] => 82
[patent_no_of_ind_claims] => 60
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20080241242.pdf
[firstpage_image] =>[orig_patent_app_number] => 11576681
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/576681 | Porous Polyelectrolyte Materials | Oct 3, 2005 | Abandoned |
Array
(
[id] => 5834709
[patent_doc_number] => 20060246540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => utility
[patent_app_number] => 11/240891
[patent_app_country] => US
[patent_app_date] => 2005-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 78
[patent_figures_cnt] => 78
[patent_no_of_words] => 74336
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20060246540.pdf
[firstpage_image] =>[orig_patent_app_number] => 11240891
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/240891 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Sep 28, 2005 | Abandoned |
Array
(
[id] => 5474288
[patent_doc_number] => 20090247454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'Method for detecting a predisposition to develop gestational diabetes mellitus and treatment for this disease'
[patent_app_type] => utility
[patent_app_number] => 11/576339
[patent_app_country] => US
[patent_app_date] => 2005-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6412
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20090247454.pdf
[firstpage_image] =>[orig_patent_app_number] => 11576339
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/576339 | Method for detecting a predisposition to develop gestational diabetes mellitus and treatment for this disease | Sep 26, 2005 | Abandoned |
Array
(
[id] => 13698
[patent_doc_number] => 07807647
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-05
[patent_title] => 'Methods and compositions for cancer therapy'
[patent_app_type] => utility
[patent_app_number] => 11/233312
[patent_app_country] => US
[patent_app_date] => 2005-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 23
[patent_no_of_words] => 23647
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/807/07807647.pdf
[firstpage_image] =>[orig_patent_app_number] => 11233312
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/233312 | Methods and compositions for cancer therapy | Sep 21, 2005 | Issued |
Array
(
[id] => 5602349
[patent_doc_number] => 20060292694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Reporter hepatocytes and other cells for drug screening and toxicity testing'
[patent_app_type] => utility
[patent_app_number] => 11/233712
[patent_app_country] => US
[patent_app_date] => 2005-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12345
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20060292694.pdf
[firstpage_image] =>[orig_patent_app_number] => 11233712
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/233712 | Reporter hepatocytes and other cells for drug screening and toxicity testing | Sep 21, 2005 | Abandoned |
Array
(
[id] => 5721266
[patent_doc_number] => 20060074041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Antisense and antigene therapeutics with improved binding properties and methods for their use'
[patent_app_type] => utility
[patent_app_number] => 11/228705
[patent_app_country] => US
[patent_app_date] => 2005-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 32107
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20060074041.pdf
[firstpage_image] =>[orig_patent_app_number] => 11228705
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/228705 | Antisense and antigene therapeutics with improved binding properties and methods for their use | Sep 15, 2005 | Abandoned |
Array
(
[id] => 5913586
[patent_doc_number] => 20060128648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Genetic suppression and replacement'
[patent_app_type] => utility
[patent_app_number] => 11/224524
[patent_app_country] => US
[patent_app_date] => 2005-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 13519
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20060128648.pdf
[firstpage_image] =>[orig_patent_app_number] => 11224524
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/224524 | Genetic suppression and replacement | Sep 11, 2005 | Abandoned |
Array
(
[id] => 5710983
[patent_doc_number] => 20060052328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Connective tissue growth factor-2'
[patent_app_type] => utility
[patent_app_number] => 11/222019
[patent_app_country] => US
[patent_app_date] => 2005-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 42623
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20060052328.pdf
[firstpage_image] =>[orig_patent_app_number] => 11222019
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/222019 | Connective tissue growth factor-2 | Sep 8, 2005 | Abandoned |
Array
(
[id] => 5602920
[patent_doc_number] => 20060293265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Methods involving aldose reductase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/210283
[patent_app_country] => US
[patent_app_date] => 2005-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 38143
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20060293265.pdf
[firstpage_image] =>[orig_patent_app_number] => 11210283
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/210283 | Methods involving aldose reductase inhibitors | Aug 22, 2005 | Abandoned |
Array
(
[id] => 83672
[patent_doc_number] => 07741299
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-22
[patent_title] => 'Therapeutic uses of inhibitors of RTP801'
[patent_app_type] => utility
[patent_app_number] => 11/207119
[patent_app_country] => US
[patent_app_date] => 2005-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 27
[patent_no_of_words] => 48097
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/741/07741299.pdf
[firstpage_image] =>[orig_patent_app_number] => 11207119
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/207119 | Therapeutic uses of inhibitors of RTP801 | Aug 15, 2005 | Issued |
Array
(
[id] => 5051897
[patent_doc_number] => 20070032442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Vector utilizing ribonuclease reductase UTR and use for inhibiting neoplastic cells'
[patent_app_type] => utility
[patent_app_number] => 11/198351
[patent_app_country] => US
[patent_app_date] => 2005-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18022
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20070032442.pdf
[firstpage_image] =>[orig_patent_app_number] => 11198351
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/198351 | Vector utilizing ribonuclease reductase UTR and use for inhibiting neoplastic cells | Aug 7, 2005 | Abandoned |
Array
(
[id] => 141124
[patent_doc_number] => 07687070
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-30
[patent_title] => 'Reagents for intracellular delivery of macromolecules'
[patent_app_type] => utility
[patent_app_number] => 11/192758
[patent_app_country] => US
[patent_app_date] => 2005-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7874
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/687/07687070.pdf
[firstpage_image] =>[orig_patent_app_number] => 11192758
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/192758 | Reagents for intracellular delivery of macromolecules | Jul 28, 2005 | Issued |
Array
(
[id] => 5667610
[patent_doc_number] => 20060172960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'Therapy and diagnosis of conditions related to telomere length and/or telomerase activity'
[patent_app_type] => utility
[patent_app_number] => 11/181020
[patent_app_country] => US
[patent_app_date] => 2005-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 40648
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20060172960.pdf
[firstpage_image] =>[orig_patent_app_number] => 11181020
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/181020 | Therapy and diagnosis of conditions related to telomere length and/or telomerase activity | Jul 11, 2005 | Abandoned |